TY - JOUR
T1 - Combining OPM and lesion mapping data for epilepsy surgery planning
T2 - a simulation study
AU - Mellor, Stephanie
AU - Timms, Ryan C.
AU - O’Neill, George C.
AU - Tierney, Tim M.
AU - Spedden, Meaghan E.
AU - Brookes, Matthew J.
AU - Wagstyl, Konrad
AU - Barnes, Gareth R.
AU - Spitzer, Hannah
AU - Ripart, Mathilde
AU - Whitaker, Kirstie
AU - Napolitano, Antonio
AU - De Palma, Luca
AU - De Benedictis, Alessandro
AU - Foldes, Stephen
AU - Zhang, Kai
AU - Hu, Wenhan
AU - Mo, Jiajie
AU - Likeman, Marcus
AU - Davies, Shirin
AU - Güttler, Christopher
AU - Lenge, Matteo
AU - Cohen, Nathan T.
AU - Tang, Yingying
AU - Wang, Shan
AU - Chari, Aswin
AU - Tisdall, Martin
AU - Bargallo, Nuria
AU - Conde-Blanco, Estefanía
AU - Pariente, Jose Carlos
AU - Pascual-Diaz, Saül
AU - Delgado-Martínez, Ignacio
AU - Pérez-Enríquez, Carmen
AU - Lagorio, Ilaria
AU - Abela, Eugenio
AU - Mullatti, Nandini
AU - O’Muircheartaigh, Jonathan
AU - Vecchiato, Katy
AU - Liu, Yawu
AU - Caligiuri, Maria Eugenia
AU - Sinclair, Ben
AU - Vivash, Lucy
AU - Willard, Anna
AU - Kandasamy, Jothy
AU - McLellan, Ailsa
AU - Sokol, Drahoslav
AU - Semmelroch, Mira
AU - Kloster, Ane G.
AU - Ribeiro, Letícia
AU - Yasuda, Clarissa
AU - Rossi-Espagnet, Camilla
AU - Hamandi, Khalid
AU - Tietze, Anna
AU - Barba, Carmen
AU - Guerrini, Renzo
AU - Gaillard, William Davis
AU - You, Xiaozhen
AU - Wang, Irene
AU - González-Ortiz, Sofía
AU - Severino, Mariasavina
AU - Striano, Pasquale
AU - Tortora, Domenico
AU - Kälviäinen, Reetta
AU - Gambardella, Antonio
AU - Labate, Angelo
AU - Desmond, Patricia
AU - Lui, Elaine
AU - O’Brien, Terence
AU - Shetty, Jay
AU - Jackson, Graeme
AU - Duncan, John S.
AU - Winston, Gavin P.
AU - Pinborg, Lars H.
AU - Cendes, Fernando
AU - Cross, J. Helen
AU - Baldeweg, Torsten
AU - Adler, Sophie
AU - The MELD Project Consortium
N1 - Funding Information:
M.J.B. is a director and chairman of, and holds founding equity in Cerca Magnetics Limited, a spin-out company whose aim is to commercialise aspects of OPM-MEG technology. This work was partly funded by a Wellcome award which involves a collaboration agreement with QuSpin, a commercial entity selling optically pumped magnetometers (OPMs).
Funding Information:
This work was supported by an Engineering and Physical Sciences Research Council (EPSRC) Healthcare Impact Partnership Grant (EP/V047264/1). GCO was supported by funding from EPSRC (EP/T001046/1) from the Quantum Technology hub in sensing and timing (sub-award QTPRF02). TMT is funded by a fellowship from Epilepsy Research UK and Young Epilepsy (FY2101). MS is supported by a Wellcome Technology development award (223736/Z/21/Z). K.W. was supported by the Wellcome Trust (215901/Z/19/Z). The MELD project was supported by the Rosetrees Trust (A2665). The Wellcome Centre for Human Neuroimaging is supported by core funding from Wellcome (203147/Z/16/Z).
Publisher Copyright:
© The Author(s) 2024.
PY - 2024/12
Y1 - 2024/12
N2 - When planning for epilepsy surgery, multiple potential sites for resection may be identified through anatomical imaging. Magnetoencephalography (MEG) using optically pumped sensors (OP-MEG) is a non-invasive functional neuroimaging technique which could be used to help identify the epileptogenic zone from these candidate regions. Here we test the utility of a-priori information from anatomical imaging for differentiating potential lesion sites with OP-MEG. We investigate a number of scenarios: whether to use rigid or flexible sensor arrays, with or without a-priori source information and with or without source modelling errors. We simulated OP-MEG recordings for 1309 potential lesion sites identified from anatomical images in the Multi-centre Epilepsy Lesion Detection (MELD) project. To localise the simulated data, we used three source inversion schemes: unconstrained, prior source locations at centre of the candidate sites, and prior source locations within a volume around the lesion location. We found that prior knowledge of the candidate lesion zones made the inversion robust to errors in sensor gain, orientation and even location. When the reconstruction was too highly restricted and the source assumptions were inaccurate, the utility of this a-priori information was undermined. Overall, we found that constraining the reconstruction to the region including and around the participant’s potential lesion sites provided the best compromise of robustness against modelling or measurement error.
AB - When planning for epilepsy surgery, multiple potential sites for resection may be identified through anatomical imaging. Magnetoencephalography (MEG) using optically pumped sensors (OP-MEG) is a non-invasive functional neuroimaging technique which could be used to help identify the epileptogenic zone from these candidate regions. Here we test the utility of a-priori information from anatomical imaging for differentiating potential lesion sites with OP-MEG. We investigate a number of scenarios: whether to use rigid or flexible sensor arrays, with or without a-priori source information and with or without source modelling errors. We simulated OP-MEG recordings for 1309 potential lesion sites identified from anatomical images in the Multi-centre Epilepsy Lesion Detection (MELD) project. To localise the simulated data, we used three source inversion schemes: unconstrained, prior source locations at centre of the candidate sites, and prior source locations within a volume around the lesion location. We found that prior knowledge of the candidate lesion zones made the inversion robust to errors in sensor gain, orientation and even location. When the reconstruction was too highly restricted and the source assumptions were inaccurate, the utility of this a-priori information was undermined. Overall, we found that constraining the reconstruction to the region including and around the participant’s potential lesion sites provided the best compromise of robustness against modelling or measurement error.
UR - http://www.scopus.com/inward/record.url?scp=85184089838&partnerID=8YFLogxK
U2 - 10.1038/s41598-024-51857-3
DO - 10.1038/s41598-024-51857-3
M3 - Article
C2 - 38311614
AN - SCOPUS:85184089838
SN - 2045-2322
VL - 14
JO - Scientific Reports
JF - Scientific Reports
IS - 1
M1 - 2882
ER -